Articles with public access mandates - Christoffer ClemmensenLearn more
Not available anywhere: 8
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
B Finan, B Yang, N Ottaway, DL Smiley, T Ma, C Clemmensen, ...
Nature medicine 21 (1), 27-36, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Reappraisal of GIP pharmacology for metabolic diseases
B Finan, TD Müller, C Clemmensen, D Perez-Tilve, RD DiMarchi, ...
Trends in Molecular Medicine 22 (5), 359-376, 2016
Mandates: Helmholtz Association
The l-α-amino acid receptor GPRC6A is expressed in the islets of Langerhans but is not involved in l-arginine-induced insulin release
S Smajilovic, C Clemmensen, LD Johansen, P Wellendorph, JJ Holst, ...
Amino acids 44, 383-390, 2013
Mandates: Danish Council for Independent Research
Celastrol-induced weight loss is driven by hypophagia and independent from UCP1
K Pfuhlmann, SC Schriever, P Baumann, DG Kabra, L Harrison, ...
Diabetes 67 (11), 2456-2465, 2018
Mandates: National Health and Medical Research Council, Australia, Helmholtz …
CB1 and GLP-1 receptors cross talk provides new therapies for obesity
P Zizzari, R He, S Falk, L Bellocchio, C Allard, S Clark, T Lesté-Lasserre, ...
Diabetes 70 (2), 415-422, 2021
Mandates: National Institute of Health and Medical Research, France, Agence Nationale …
The anorectic and thermogenic effects of pharmacological lactate in male mice are confounded by treatment osmolarity and co-administered counterions
J Lund, AW Breum, C Gil, S Falk, F Sass, MS Isidor, O Dmytriyeva, ...
Nature Metabolism 5 (4), 677-698, 2023
Mandates: German Research Foundation, European Commission
GLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in mice
L Decarie-Spain, A Fisette, Z Zhu, B Yang, RD DiMarchi, MH Tschoep, ...
Neuropharmacology 151, 55-63, 2019
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging
G Skovbjerg, U Roostalu, CG Salinas, JL Skytte, J Perens, ...
Neuropharmacology 238, 109637, 2023
Mandates: Innovation Fund Denmark
Available somewhere: 52
FXR is a molecular target for the effects of vertical sleeve gastrectomy
KK Ryan, V Tremaroli, C Clemmensen, P Kovatcheva-Datchary, ...
Nature 509 (7499), 183-188, 2014
Mandates: US National Institutes of Health
Animal models of obesity and diabetes mellitus
M Kleinert, C Clemmensen, SM Hofmann, MC Moore, S Renner, ...
Nature Reviews Endocrinology 14 (3), 140-162, 2018
Mandates: US National Institutes of Health
Blood BDNF concentrations reflect brain-tissue BDNF levels across species
AB Klein, R Williamson, MA Santini, C Clemmensen, A Ettrup, M Rios, ...
International Journal of Neuropsychopharmacology 14 (3), 347-353, 2011
Mandates: US National Institutes of Health
The new biology and pharmacology of glucagon
TD Müller, B Finan, C Clemmensen, RD DiMarchi, MH Tschöp
Physiological reviews 97 (2), 721-766, 2017
Mandates: German Research Foundation
Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis
K Fischer, HH Ruiz, K Jhun, B Finan, DJ Oberlin, V Van Der Heide, ...
Nature medicine 23 (5), 623-630, 2017
Mandates: US National Institutes of Health, German Research Foundation, Helmholtz …
Gut-brain cross-talk in metabolic control
C Clemmensen, TD Müller, SC Woods, HR Berthoud, RJ Seeley, ...
Cell 168 (5), 758-774, 2017
Mandates: US National Institutes of Health, German Research Foundation, Helmholtz …
Unimolecular polypharmacy for treatment of diabetes and obesity
MH Tschöp, B Finan, C Clemmensen, V Gelfanov, D Perez-Tilve, ...
Cell metabolism 24 (1), 51-62, 2016
Mandates: Helmholtz Association
Will the COVID-19 pandemic worsen the obesity epidemic?
C Clemmensen, MB Petersen, TIA Sørensen
Nature Reviews Endocrinology 16 (9), 469-470, 2020
Mandates: Carlsberg Foundation DK
Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease
B Finan, C Clemmensen, Z Zhu, K Stemmer, K Gauthier, L Müller, ...
Cell 167 (3), 843-857. e14, 2016
Mandates: German Research Foundation, Helmholtz Association, European Commission
Anti-obesity therapy: from rainbow pills to polyagonists
TD Müller, C Clemmensen, B Finan, RD DiMarchi, MH Tschöp
Pharmacological reviews 70 (4), 712-746, 2018
Mandates: German Research Foundation, Helmholtz Association, European Commission …
GLP-1/glucagon receptor co-agonism for treatment of obesity
MA Sánchez-Garrido, SJ Brandt, C Clemmensen, TD Müller, RD DiMarchi, ...
Diabetologia 60, 1851-1861, 2017
Mandates: Helmholtz Association
GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet
C Clemmensen, J Chabenne, B Finan, L Sullivan, K Fischer, D Küchler, ...
Diabetes 63 (4), 1422-1427, 2014
Mandates: German Research Foundation
Publication and funding information is determined automatically by a computer program